EXAS vs ORRF · rev $2.76B vs P/E 8.8, rev $27.3M
EXACT Sciences Corporation (EXAS) versus Orrstown Financial Services Inc (ORRF) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Orrstown Financial Services Inc (ORRF) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported ORRF revenue for 2024-12-31 was $27.3M. Net income was $22.1M. Revenue was up 40.2% from 2023-12-31 to 2024-12-31. ORRF currently screens at market cap $756.0M and trailing P/E 8.8.
EXAS currently screens at market cap $20.03B. ORRF currently screens at market cap $756.0M and trailing P/E 8.8.
Not investment advice. Open the EXAS and ORRF stock pages for the full models.
Not investment advice.